AM 6545 – synthetic, CB1 antagonist

 

Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes?                                                             (full – 2010)  http://www.jci.org/articles/view/44099?search[abstract_text]=&search[article_text]=cannabinoid&search[a   uthors_text]=&search[fpage]=&search[title_text]=&search[volume]=

 

 

Share a link for